Bend Bioscience

Bend Bioscience

Private
Bend, OregonHealthcare & Life Scienceshttps://bendbioscience.com/

Last Round

Corporate Funding

Oct 11, 2022

Momentum Score

25 /100

Company Overview

Bend Bioscience is a contract development and manufacturing organization (CDMO) company that provides end-to-end services including formulation development, clinical and commercial manufacturing, and testing of solid, liquid, and semi-solid dosage forms.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract development and manufacturing organizationCDMObioavailability enhancementsmall molecule formulationdrug formulationparticle engineeringcGMP manufacturingspray-dried dispersionsdrug deliveryoral solid dosagecontrolled release technologyhot melt extrusionpharma supply chainin-silico modelingAI-augmented drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bend Bioscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bend Bioscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingOct 11, 2022
Buyout/LBOJan 19, 2021

Key People

Founding team and executive leadership

Tatum Reed

Head Of Rhythm & Results, Office Of The CEO

Executive Team

Rick Schindewolf

Chief Financial Officer

Executive Team

Jacob Werlinger

Chief Operating Officer

Executive Team

Bend Bioscience Investors

Notable investors and investment history

InvestorRounds
Goldman Sachs Specialty Lending GroupBuyout/LBO
Signet Healthcare PartnersBuyout/LBO, Private Equity
QHP CapitalCorporate Funding, Buyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors grew 478% MoM, from 800 to 4.6K.

  • May 3, 2025

    Monthly visitors increased 69% MoM.

Bend Bioscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bend Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bend Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersBend, Oregon
Employee Range427
Year Founded2006
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.